Rare diseases
Investigational molecules
Locations
Study on Crizotinib for Treating Severe Neurofibromatosis Type 2 in Children Not Eligible for Surgery or Radiotherapy
PolandStudy on the Effectiveness of Pembrolizumab and Ipilimumab in Melanoma Patients with Brain Metastases Requiring Steroid Treatment
DenmarkStudy on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity
GermanyStudy on Stopping Dimethyl Fumarate and Drug Combination in Patients Aged 55+ with Inactive Relapsing-Remitting Multiple Sclerosis
FranceStudy of tislelizumab immunotherapy in patients with liver cancer (hepatocellular carcinoma) who have moderately impaired liver function (Child-Pugh B)
FranceStudy on Obinutuzumab for Adolescents with Active Lupus Nephritis and Safety in Children Aged 5 to 12
FranceStudy on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors
BulgariaStudy on the Safety of Encorafenib, Binimetinib, and Ribociclib for Patients with Solid Tumors
CzechiaStudy on the Effects of Cerebrolysin and Sodium Chloride for Recovery in Patients with Moderate to Severe Traumatic Brain Injury
RomaniaStudy on Treating Solid Tumors with Genetically Modified T-Cells (IMA203, IMA203CD8) and Nivolumab for Patients with Recurrent or Refractory Conditions
GermanyStudy on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis
BelgiumStudy on the Effectiveness and Safety of Tocilizumab and Adalimumab for Patients with Severe Uveitis in Behçet’s Disease
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
